Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies

Yang, Wen-jun; Wang, Ming-yue; Pan, Fu-ze; Shi, Chen; Cen, Hong

doi:10.1186/s12957-017-1183-7

World Journal of Surgical Oncology

Table 1 Overview of studies included in the current meta-analysis

From: Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies

Author	Year	Country	Ethics	Cancer	Disease confirmed	Resource	Case	Control	Genotyping	NOS score
London	1997	America	mix Ethics	Lung cancer	NA	PB	339	703	RT-PCR	7
Marchand	2000	America	mix Ethics	Lung cancer	Histological	PB	323	437	PCR-RFLP	8
Misra	2001	Finland	Caucasian	Lung cancer	Histological	PB	315	311	PCR-RFLP	8
Xu	2002	America	Caucasian	Lung cancer	Histological	HB	989	1128	PCR-RFLP	7
Lv	2002	China	Asian	Lung cancer	Histological	PB	314	320	PCR	8
Kantarct	2002	America	Caucasian	Lung cancer	NA	HB	307	307	NA	5
Feyler	2002	France	Caucasian	Lung cancer	Histological	HB	150	172	capillary PCR	7
Dally	2002	Germany	Caucasian	Lung cancer	NA	HB	625	340	PCR-RFLP.	6
Chevriera	2003	France	Caucasian	Lung cancer	Histological	HB	243	245	PCR-RFLP	7
Skuladottira	2004	Denmark	Caucasian	Lung cancer	NA	PB	122	396	NA	6
Chana	2004	China	Asian	Lung cancer	NA	HB	75	162	PCR-RFLP	6
Harms	2004	America	Caucasian	Lung cancer	Pathological	PB	110	119	MALDI-TOF	8
Wu	2004	China	Asian	Lung cancer	Histological	PB	98	112	PCR	8
Schabath	2005	America	Caucasian	Lung cancer	Histological	HB	837	618	PCR-RFLP	7
Park	2006	Korea	Asian	Lung cancer	Histological	HB	432	432	PCR-RFLP	7
Larsen	2006	Australia	Caucasian	Lung cancer	Cytological or histological	HB	627	624	PCR	7
Yanga	2007	Korean	Asian	Lung cancer	Histological	HB	318	353	PCR-RFLP	7
Zienolddiny	2008	Norway	Caucasian	Lung cancer	Pathologists	PB	258	297	NA	7
Yoon	2008	Korea	Asian	Lung cancer	Histological	HB	213	213	Taqman probe	7
Rotunno	2009	America	Caucasian	Lung cancer	Histology	PB	185	2011	NA	7
Klinchid	2009	Thailand	Asian	Lung cancer	Histological	HB	88	81	PCR-RFLP	7
Kiyohara	2014	Japan	Asian	Lung cancer	Histological	HB	462	379	TaqMan	7
Bag	2014	India	Asian	Lung cancer	Tissue diagnosis	HB	26	37	PCR-RFLP	7
Cascorbi	2000	Germany	Caucasian	Mix	NA	PB	696	270	PCR-RFLP	7
Arslan	2011	Turkey	Caucasian	Mix	Histological	HB	220	418	PCR-RFLP	7
Lin	2004	Taiwan	Asian	Breast cancer	Medical charts and pathology	PB	99	366	PCR-RFLP	8
Ahn	2004	Canada	Caucasian	Breast cancer	NA	PB	1011	1067	PCR-RFLP.	7
Yang	2007	America	Caucasian	Breast cancer	NA	PB	406	392	PCR-RFLP	7
Li	2009	America	Caucasian	Breast cancer	NA	NA	477	462	PCR-RFLP.	5
Tsai	2012	Taiwan	Asian	Breast cancer	NA	NA	260	224	PCR-RFLP	5
Zhang	2007	China	Asian	Acute leukemia	French-American-British criteria	HB	135	187	Taqman	7
Krajinovic	2002	Canada	Caucasian	ALL	Hematology-oncology	HB	169	337	PCR-RFLP	7
Silveira	2010	Brazil	mix Ethics	ALL	Immunophenotyping	NA	124	300	PCR-RFLP	6
Matsuo	2001	Japan	Asian	Lymphoma	Histological	HB	372	241	PCR-RFLP	7
Saygilii	2009	Turkey	Caucasian	Mix	NA	HB	62	40	TaqMan	6
Wang	2006	America	Caucasian	NHL	Histopathology	PB	1082	905	NA	7
Farawela	2012	Egypt	Asian	NHL	Biopsy	HB	100	100	RT-PCR	7
Funke	2009	Germany	Caucasian	Colorectal cancer	NA	PB	627	603	PCR	7
Li	2011	China	Asian	Colorectal cancer	Histological	HB	325	345	PCR-RFLP	7
Matsuo	2001	Japan	Asian	Esophageal cancer	NA	HB	91	241	PCR-RFLP	6
Li	2008	China	Asian	Esophageal cancer	Pathologists	PB	126	169	PCR-RFLP	8
Li	2011	China	Asian	Esophageal cancer	Histopathologic	HB	94	280	NA	6
Zhu	2006	China	Asian	Gastric cancer	Biopsy or surgical specimens	NA	127	139	PCR-RFLP	6
Wang	2011	China	Asian	Gastric cancer	Pathological	HB	62	61	ASP-PCR	7
Jang	2012	China	Asian	Gastric cancer	Pathological	HB	117	105	PCR-RFLP	7
Pakakasama	2003	America	Caucasian	Hepatoblastoma	PCR-SSCP	PB	48	180	Pyrosequencing	7
Nahon	2011	France	Caucasian	Hepatocellular cancer	Barcelona criteria	HB	84	121	NA	6
Carmo	2012	Brazil	Caucasian	Hepatocellular cancer	AASLD guidelines	HB	32	252	PCR-amplified	7
Mustea	2007	Germany	Caucasian	Cervical cancer	Histological	HB	149	126	PCR-RFLP	7
Olson	2004	America	Caucasian	Ovarian cancer	NA	PB	122	179	TaqMan	7
CastilloTong	2014	Austria	Caucasian	Ovarian cancer	Histopathological	NA	305	299	TaqMan probes	6
Hung	2004	Italy	Caucasian	Bladder cancer	Histological	HB	201	214	PCR-RFLP	7
Hsieh	2010	Taiwan	Asian	Leiomyoma	Pathological	HB	158	156	PCR-RFLP	7
Guo	2010	China	Asian	Nasopharyngeal carcinoma	Biopsy	HB	358	629	PCR-RFLP	7
Wu	2010	Taiwan	Asian	Oral cavity	Pathological	HB	122	122	PCR	7
Oliveira	2007	Brazil	mix Ethics	Osteosarcoma	NA	HB	78	157	PCR-RFLP	6
Price	2008	Canada	Caucasian	Pancreatic cancer	Histological	HB	122	331	PCR	7
Buch	2008	America	Caucasian	Squamous cell carcinoma	Biopsy-verified	PB	193	414	PCR-RFLP	8
Choi	2008	America	Caucasian	Prostate cancer	Pathology	HB	493	1332	NA	6
Tefik	2013	Turkey	Caucasian	Prostate cancer	Histological	HB	155	195	PCR	7

NA not available, ALL acute lymphoblastic leukemia, NAL non-Hodgkin lymphoma, mix: 2 or more cancer type, PB population base, HB hospital base, PCR-RFLP polymerase chain reaction restriction fragment length polymorphism, RT-PCR real-time polymerase chain reaction

Back to article page

ISSN: 1477-7819

Contact us

General enquiries: journalsubmissions@springernature.com